AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. By joining our Future Opportunities Talent Pipeline for North Chicago, you express interest in becoming part of a collaborative and innovative environment focused on ethical scientific discovery and patient care. We welcome professionals with diverse backgrounds and expertise who are motivated to contribute to meaningful advancements in healthcare. Earlier this year, we announced a $575 million investment to build two new active pharmaceutical ingredient (API) pharmaceutical facilities in North Chicago, Illinois. These new state-of-the-art facilities will integrate advanced manufacturing technologies with artificial intelligence (AI) to support the production of AbbVie's next-generation neuroscience and obesity medications. Active pharmaceutical ingredient manufacturing is a complex, multi-step process that involves producing the active components responsible for a medication's therapeutic effects. Over the past six months, AbbVie has announced plans to significantly expand its API manufacturing capabilities and capacity in the U.S. In September 2025, AbbVie broke ground on the first phase of this investment, a new chemical synthesis facility that will enable the return of API production for select neuroscience, immunology and oncology products from Europe and Asia to the U.S.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Education Level
No Education Listed